Home > Investor

Investor

Share Trends
Stock Performance
Warsaw Stock Exchange
Bulgarian Stock Exchange
Corporate News
28 October 2021
The Executive Director of Sopharma met with Vice President of Vietnam Mrs. Vo Thi Anh Xuan
Financial News
6 August 2025
Notification of sale of treasury shares as of 6 August, 2025
6 August 2025
Notification of sale of treasury shares as of 6 August, 2025
5 August 2025
Correction of the text of the notification regarding sold repurchased shares as of 5 August, 2025
Financial Highlights 31 March, 2022
397 570
BGN '000 Revenue
34 368
BGN '000 EBITDA
21 827
BGN '000 Revenue from operating profit
22 560
BGN '000 Net profit for the year
0.17
BGN Earnings per share

Next events
20 August 2025
Revenues for January-July 2025
30 August 2025
Publication of the Consolidated financial statements for Q2 of 2025

Equity story

85+ year track record in the pharma industry

  • Leadership
  • Growth
  • Portfolio
  • Profitability
  • Business Model
  • M&A